STRUCTURE AND MECHANISM OF PROSTAGLANDIN H2 SYNTHASE

Information

  • Research Project
  • 6547433
  • ApplicationId
    6547433
  • Core Project Number
    R01GM055171
  • Full Project Number
    7R01GM055171-05
  • Serial Number
    55171
  • FOA Number
    PA-95-35
  • Sub Project Id
  • Project Start Date
    1/1/1998 - 27 years ago
  • Project End Date
    12/31/2002 - 22 years ago
  • Program Officer Name
    LEWIS, CATHERINE D.
  • Budget Start Date
    9/2/2001 - 24 years ago
  • Budget End Date
    12/31/2001 - 23 years ago
  • Fiscal Year
    2001
  • Support Year
    5
  • Suffix
  • Award Notice Date
    12/10/2001 - 24 years ago
Organizations

STRUCTURE AND MECHANISM OF PROSTAGLANDIN H2 SYNTHASE

DESCRIPTION: (adapted from applicant's abstract) The goal of this project is to develop a structural understanding of how prostaglandin H2synthase (PGHS) functions focusing on both the enzyme's recognition of inhibitors and fatty acid substrates and on the relationship between the enzyme's two distinct activities. PGHS catalyzes the conversion of arachidonic acid to prostaglandin H2 and this process is inhibited by nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, ibuprofen, naproxen, and indomethacin. The specific aims of the project are: (1) exploration of active site plasticity: structures of PGHS complexed with conformationally constrained indomethacin analogs will be determined to investigate the ability of the active site to adopt alternate conformations in recognizing various NSAIDs, and to better understand the possible mechanism by which the cyclooxygenase and peroxidase active sites communicate with each other. (2) Analysis of fatty acid binding and cyclooxygenase catalysis. The nature of the Michaelis complex of arachidonic acid or related fatty acids bound to PGHS will be determined using crystals soaked in substrate solutions under anaerobic conditions. The structural data will be used to elucidate the spatial relationship of the substrate with the radical tryosine 385 in addition to any conformational constraints imposed by the enzyme on the substrate. The purpose of this specific aim is to examine the structures of fatty acids substrates and inhibitors bound to PGHS to test whether tyr-385 is situated appropriately to act as a hydrogen atom abstractor. Specific Aim (3) Examination of the relationship between the peroxidase and cyclooxygenase catalytic activities: structures will be determined of peroxidase deficient forms of PGHS (using chemical modification techniques and/or reconstitution with non-iron metalloporphyrins. Comparison of these structures with that of the peroxidase competent form of the enzyme will contribute to the understanding of the peroxidase mechanism by revealing features of the active site necessary for substrate binding/catalysis. Finally, structures of different cyclooxygenase or peroxidase deficient forms of the enzyme will be determined to help clarify the relationship between the two activities.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R01
  • Administering IC
    GM
  • Application Type
    7
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    121481
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NIGMS:121481\
  • Funding Mechanism
  • Study Section
    BBCB
  • Study Section Name
    Biophysics and Biophysical Chemistry B Study Section
  • Organization Name
    MCP HAHNEMANN UNIVERSITY
  • Organization Department
    BIOCHEMISTRY
  • Organization DUNS
  • Organization City
    PHILADELPHIA
  • Organization State
    PA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    191021192
  • Organization District
    UNITED STATES